# BlinkRx

> BlinkRx is the enterprise platform of New York-based Blink Health, founded by brothers Geoffrey and Matthew Chaiken. Billed as a 'pharma-to-patient cloud,' it lets pharmaceutical manufacturers run the entire prescription journey - pricing, prior authorization, copay assistance, fulfillment, free home delivery, and adherence support - on a single system. Its consumer side offers cash-pay discounts and an online pharmacy. The company says it supports millions of patients across all 50 states and has raised hundreds of millions in venture funding.

- **Founded:** 2014
- **Headquarters:** New York, United States
- **Founders:** Geoffrey Chaiken (Co-Founder & CEO), Matthew Chaiken (Co-Founder & President)
- **Team size:** approx. 560 (third-party estimate; LinkedIn lists a wider band that includes pharmacy and contract staff)
- **Products:** BlinkRx Platform, Blink Quick Save, Blink Health Online Pharmacy, Smart Routing / Digital Concierge, Operation Access Now
- **Notable:** Built and marketed as the world's first 'pharma-to-patient cloud.', Says its platform supports millions of patients across all 50 states., Reports an average 52% increase in patient starts and 41% increase in fills per patient for programs on the platform (company figures).

## Products & services

- **BlinkRx Platform** — A prescription lifecycle management platform, marketed as the 'pharma-to-patient cloud,' that lets life-sciences companies design and run the full prescription journey: pricing, prior authorization, copay assistance, fulfillment, home delivery, adherence, and reimbursement support.
- **Blink Quick Save** — A consumer cash-pay discount product offering lower prices on cash-pay medications at thousands of US pharmacies, competing with legacy coupon and discount-card solutions.
- **Blink Health Online Pharmacy** — Consumer app and website (blinkhealth.com) where patients prepay for prescriptions online and choose pharmacy pickup or free home delivery.
- **Smart Routing / Digital Concierge** — Automatically applies available copay assistance and routes each prescription to the lowest available price across Blink's pharmacy network.
- **Operation Access Now** — Launched August 2025, a turnkey program that lets pharmaceutical manufacturers stand up direct-to-patient (DTP) and direct-to-business (DTB) sales channels in as little as 21 days, supporting both cash-pay and insured patients.

## Achievements

- Built and marketed as the world's first 'pharma-to-patient cloud.'
- Says its platform supports millions of patients across all 50 states.
- Reports an average 52% increase in patient starts and 41% increase in fills per patient for programs on the platform (company figures).
- Raised a reported $140M Series D in 2024 led by 1789 Capital.
- Launched Operation Access Now (2025), enabling manufacturer direct-to-patient channels in as little as 21 days.
- CEO Geoffrey Chaiken recognized by Crain's New York Business.

## Latest updates

- **2024-11** — Reported Series D of approximately $140M led by 1789 Capital, valuing the company in the ~$1.3B range.
- **2025-02** — Announced changes to its Board of Directors alongside the Series D financing.
- **2025-08** — Launched Operation Access Now, a turnkey program for manufacturer direct-to-patient and direct-to-business sales channels deployable in as little as 21 days.
- **2025-12** — Hosted a summit attended by major US drugmakers focused on direct-to-patient drug distribution.

## Links

- Website: https://blinkrx.com
- LinkedIn: https://www.linkedin.com/company/blinkrx
- Twitter/X: https://twitter.com/blinkhealth
- Instagram: https://www.instagram.com/blinkhealth/
- Facebook: https://www.facebook.com/BlinkHealth

---

Profile page: https://yespress.io/blinkrx
Published by YesPress — https://yespress.io
Last updated: 2026-06-15